Premature Infant: Respiratory Care and Management

A premature infant is born before 37 weeks of gestation, before normal fetal growth and organ development have been completed. Prematurity is especially important in respiratory care because the lungs, pulmonary circulation, chest wall, respiratory-control centers, and antioxidant defenses may still be immature at birth.

As a result, premature infants are vulnerable to respiratory distress syndrome, apnea, oxygen toxicity, bronchopulmonary dysplasia, and complications from mechanical ventilation. The earlier an infant is born and the lower the birth weight, the greater the likelihood that respiratory support will be required.

What Is a Premature Infant?

A premature, or preterm, infant is a newborn delivered before 37 completed weeks of gestation. Prematurity encompasses a wide range of developmental maturity. An infant born only a few weeks early may require relatively little respiratory assistance, while an infant born many weeks before term may have profoundly immature lungs and require intensive respiratory support.

Gestational age is one of the most important factors affecting neonatal outcome because fetal organs mature progressively throughout pregnancy. The respiratory system undergoes major structural and functional changes during the second and third trimesters. When birth occurs before these processes are complete, the infant must begin breathing air at a developmental stage when the lungs may not yet be fully prepared for independent gas exchange.

Birth weight also influences risk. Very-low-birth-weight and extremely-low-birth-weight infants tend to have more severe respiratory problems because low weight often reflects extreme prematurity. Smaller infants also have limited metabolic reserves, immature temperature regulation, smaller airways, and increased vulnerability to complications involving the brain, eyes, gastrointestinal tract, and cardiovascular system.

The respiratory care of a premature infant therefore involves more than simply maintaining acceptable blood gas values. Clinicians must support ventilation and oxygenation while allowing the lungs to continue growing and developing with as little treatment-related injury as possible.

Fetal Lung Development and Prematurity

Understanding premature infant respiratory disease requires an understanding of fetal lung development. The lungs develop through several overlapping stages, including the embryonic, pseudoglandular, canalicular, saccular, and alveolar phases.

During the canalicular phase, which occurs at approximately 17 to 26 weeks of gestation, the future gas-exchanging portions of the lungs become increasingly organized. Pulmonary capillaries develop around the distal air passages, and type I and type II pneumocytes begin to appear.

Type I pneumocytes eventually form the thin alveolar surfaces across which oxygen and carbon dioxide are exchanged. Type II pneumocytes produce pulmonary surfactant, which is essential for stabilizing the alveoli.

Survival outside the uterus begins to become possible during the later part of the canalicular stage, around 22 to 24 weeks, because vascular development, respiratory structures, and surfactant production have progressed enough to permit limited pulmonary function. However, the lungs at this stage remain extremely immature.

The saccular phase extends from approximately 26 to 35 or 36 weeks. During this period, the distal airspaces become more complex, pulmonary vascular development continues, and the surface available for gas exchange increases.

Alveolar development continues before birth and extensively after birth. Therefore, an extremely premature infant is born at a time when normal alveolar development is still incomplete. Respiratory disease and aggressive respiratory support during this period can interfere with subsequent lung growth.

Why Premature Infants Have Respiratory Problems

Several characteristics make premature infants particularly susceptible to respiratory failure. Surfactant may be deficient or functionally immature, which increases alveolar surface tension and promotes collapse. The lungs contain fewer mature gas-exchanging structures, reducing the surface area available for oxygen and carbon dioxide exchange.

The premature chest wall is also highly compliant. Instead of providing a rigid structure that supports lung expansion, the chest wall may retract inward during inspiration when the infant generates negative intrathoracic pressure. This contributes to visible intercostal, subcostal, or substernal retractions.

Respiratory muscles may fatigue quickly because premature infants have limited energy reserves and must often work much harder than term infants to maintain ventilation. Functional residual capacity can be difficult to maintain, especially when surfactant deficiency promotes alveolar collapse.

The neurologic control of breathing is also immature. Premature infants may fail to respond normally to hypoxemia or changes in carbon dioxide levels, increasing their risk of apnea.

The pulmonary circulation also remains developmentally immature. Hypoxemia and acidosis can increase pulmonary vascular resistance, promoting pulmonary hypertension and right-to-left shunting through fetal circulatory pathways. This can further worsen oxygenation.

These physiologic problems often occur simultaneously, which explains why a relatively small premature infant can deteriorate rapidly when respiratory disease develops.

Respiratory Distress Syndrome

Respiratory distress syndrome, or RDS, is one of the most important respiratory disorders associated with prematurity. It was historically referred to as hyaline membrane disease.

The incidence of RDS rises dramatically as gestational age decreases. More than 80% of infants born before approximately 28 weeks may develop the disorder, while the risk becomes progressively lower as fetal lung maturity improves.

The fundamental abnormality in RDS is inadequate functioning of pulmonary surfactant combined with structural immaturity of the lungs.

Role of Surfactant

Pulmonary surfactant is produced by type II alveolar cells and consists primarily of lipids along with specialized proteins. One important phospholipid component is dipalmitoylphosphatidylcholine.

Surfactant spreads across the air-liquid interface inside the alveoli and reduces surface tension. This action is particularly important during expiration, when alveoli become smaller and would otherwise be more likely to collapse.

In a premature infant, surfactant may be present within type II cells but may not be adequately released into the alveoli. Surfactant that does reach the alveolar surface may also be incompletely developed and less effective.

When surfactant is deficient, surface tension rises significantly. The alveoli become unstable and repeatedly collapse during expiration. Greater pressure is then required to reopen them during the next inspiration.

The resulting atelectasis reduces functional residual capacity, decreases pulmonary compliance, increases the work of breathing, and creates areas of severe ventilation-perfusion mismatch.

Blood may continue flowing through poorly ventilated or collapsed lung regions, creating intrapulmonary shunting and hypoxemia. Increased alveolar surface tension can also promote movement of fluid from pulmonary capillaries into the alveoli, further impairing gas exchange.

Effects of Hypoxemia and Acidosis

As RDS worsens, hypoxemia and respiratory acidosis may develop. Hypoxemia and acidosis increase pulmonary vascular resistance, which raises pulmonary arterial pressure.

Elevated pulmonary vascular resistance may increase right-to-left shunting through fetal circulatory pathways. Blood then bypasses the lungs without becoming adequately oxygenated, worsening systemic hypoxemia.

Hypoxemia and acidosis may also interfere with additional surfactant production. This creates a destructive cycle in which alveolar collapse, impaired gas exchange, pulmonary vasoconstriction, and surfactant dysfunction reinforce one another.

Signs and Symptoms of RDS

RDS typically becomes apparent shortly after birth. The infant may demonstrate progressively increasing respiratory effort as the lungs become more difficult to expand.

Common findings include:

• Tachypnea
• Nasal flaring
• Intercostal, subcostal, or substernal retractions
• Expiratory grunting
• Cyanosis
• Decreased breath sounds
• Increasing oxygen requirements

Grunting is an important compensatory mechanism. The infant partially closes the glottis during expiration, creating positive pressure within the airways. This helps slow expiration and maintain alveolar volume.

Retractions are also common because the premature chest wall is highly compliant while the lungs affected by RDS are relatively stiff. As the infant generates greater inspiratory pressure, the soft chest wall is pulled inward.

Diagnosing Respiratory Distress Syndrome

Diagnosis of RDS is based on gestational age, clinical findings, oxygen requirements, blood gas abnormalities, and chest radiography.

A chest radiograph may demonstrate low lung volumes accompanied by diffuse hazy, reticulogranular, or ground-glass opacities. Air bronchograms may also be visible.

The reticulogranular pattern develops because aerated airways are surrounded by collapsed alveoli. Air bronchograms appear when air-filled bronchi are outlined by adjacent areas of atelectasis or consolidation.

Blood gas analysis may demonstrate significant hypoxemia. Respiratory acidosis may develop when ventilation becomes inadequate and carbon dioxide begins accumulating.

Other causes of neonatal respiratory distress must also be considered, including pneumonia, congenital heart disease, transient tachypnea, pulmonary hypertension, airway abnormalities, and infection.

Assessing Fetal Lung Maturity

Before delivery, fetal lung maturity can sometimes be estimated using substances present in amniotic fluid.

One traditional measurement is the lecithin-to-sphingomyelin ratio. A ratio of approximately 2:1 or greater generally suggests adequate pulmonary maturity and a relatively low likelihood of RDS. Lower ratios indicate progressively greater risk of surfactant deficiency.

The presence of phosphatidylglycerol is another sign of lung maturity. This phospholipid normally appears later in gestation and provides additional evidence that surfactant development has progressed.

These measurements are less central to modern neonatal management than they once were, but they demonstrate the close relationship between fetal maturation, surfactant production, and the risk of respiratory distress.

Antenatal Corticosteroids

When premature delivery is anticipated, antenatal corticosteroids may be administered to the mother to accelerate fetal lung maturation.

Betamethasone and dexamethasone are commonly used for this purpose. These medications promote maturation of fetal lung tissue and improve surfactant production and function.

Antenatal corticosteroids can reduce the incidence and severity of respiratory distress syndrome and decrease the risk of additional complications associated with prematurity, including intracranial hemorrhage.

For this reason, delaying premature delivery long enough to allow corticosteroids to take effect can have substantial respiratory benefits when clinically appropriate.

Initial Respiratory Assessment After Birth

Premature delivery should be considered a high-risk situation, particularly when birth occurs many weeks before term.

Immediately after birth, the infant should be assessed for respiratory effort, heart rate, muscle tone, reflex response, and color. These findings are incorporated into the Apgar assessment, although necessary resuscitation should never be delayed for the purpose of obtaining a score.

Preductal pulse oximetry is commonly obtained from the right hand when supplemental oxygen is required or when significant cyanosis or pallor is present.

Oxygen saturation is normally relatively low during the first moments after birth and rises gradually during neonatal transition. Therefore, oxygen should not automatically be increased to produce adult saturation values immediately after delivery. The infant should continue to be observed for delayed respiratory distress, apnea, hypoxemia, and increasing oxygen requirements.

Gestational Age Assessment

Gestational age can be estimated using physical and neurologic findings after birth. The Ballard assessment evaluates characteristics that change progressively during fetal development.

Physical and neuromuscular findings may include posture, arm recoil, wrist flexibility, popliteal angle, scarf sign, and heel-to-ear positioning.

More mature infants generally demonstrate stronger flexion and increased muscle tone. Extremely premature infants tend to have less resistance to passive movement and less developed physical characteristics.

Gestational assessment helps clinicians estimate developmental maturity and anticipate complications commonly associated with a particular degree of prematurity.

CPAP for Premature Infants

Continuous positive airway pressure is one of the most important respiratory therapies used in premature infants. CPAP provides positive pressure throughout the respiratory cycle while allowing the infant to breathe spontaneously. The pressure helps maintain alveolar expansion during expiration and increases functional residual capacity.

In infants with surfactant deficiency, this is particularly beneficial because alveoli tend to collapse repeatedly at the end of expiration.

CPAP can improve oxygenation, reduce intrapulmonary shunting, improve pulmonary compliance, stabilize the compliant chest wall, and reduce work of breathing. Nasal prongs or a nasal mask are commonly used because they allow respiratory support without requiring an endotracheal tube.

Indications for CPAP

CPAP may be considered when a premature infant is breathing spontaneously but demonstrates signs of inadequate lung expansion or oxygenation.

Indications can include RDS, atelectasis, pulmonary edema, apnea of prematurity, transient tachypnea, tracheomalacia, and respiratory support following extubation.

Premature infants demonstrating tachypnea, nasal flaring, grunting, retractions, or persistent hypoxemia despite supplemental oxygen may benefit from CPAP. Typical pressures may begin around 4 to 6 cm H₂O, although the exact setting depends on the infant’s condition and response.

Other Forms of Noninvasive Respiratory Support

High-flow nasal cannula and nasal intermittent positive-pressure ventilation are also used in premature infants. High-flow nasal cannula can provide some degree of positive airway pressure while washing carbon dioxide from upper-airway dead space. It may be used after extubation and can sometimes provide support similar to nasal CPAP while producing less nasal trauma.

Nasal intermittent mandatory ventilation, sometimes referred to as nasal intermittent positive-pressure ventilation, adds intermittent positive-pressure breaths to a continuous distending pressure.

This approach provides more ventilatory assistance than CPAP alone and may reduce apnea or decrease the likelihood that some infants will require endotracheal intubation.

Surfactant Replacement Therapy

Exogenous surfactant replacement is a major treatment for premature infants with moderate to severe RDS. Several preparations are available, including products derived from bovine or porcine sources as well as synthetic preparations. Surfactant is delivered directly into the trachea so that it can spread across the alveolar surfaces.

Replacement therapy reduces alveolar surface tension, improves compliance, increases functional residual capacity, and improves oxygenation.

Surfactant may be administered prophylactically to selected extremely premature infants or as rescue therapy after RDS has developed.

Infants requiring relatively high inspired oxygen concentrations while receiving CPAP, particularly an FiO₂ above approximately 0.40, may be candidates for surfactant depending on the clinical situation. Severe respiratory distress or recurrent apnea may also indicate the need for more aggressive treatment.

Rapid Improvement After Surfactant

One of the most important considerations following surfactant administration is that pulmonary compliance may improve very quickly. Before surfactant, relatively high ventilating pressures may be required to move a small tidal volume through stiff lungs. Once surfactant begins working, the same pressure may suddenly produce a much larger tidal volume.

If ventilator settings are not adjusted, the infant can develop excessive ventilation, hypocapnia, volutrauma, or pneumothorax. Inspired oxygen concentration may also need to be reduced rapidly as oxygenation improves.

Continuous assessment of chest movement, oxygen saturation, tidal volume, airway pressure, blood gases, and overall respiratory status is therefore essential following surfactant treatment.

Potential complications include temporary desaturation, bradycardia, airway obstruction, apnea, pulmonary hemorrhage, uneven surfactant distribution, and excessive ventilation.

INSURE and Early Extubation

One strategy used in premature infants is the INSURE approach, which stands for intubation, surfactant administration, and extubation. The infant is briefly intubated so surfactant can be delivered directly into the trachea. After stabilization and improvement, the infant is extubated and transitioned to nasal CPAP.

The purpose of this approach is to provide surfactant while limiting the duration of invasive mechanical ventilation.

Modern neonatal respiratory care generally favors early noninvasive support and selective surfactant administration rather than routine prolonged mechanical ventilation whenever the infant can maintain adequate spontaneous breathing.

Mechanical Ventilation

Mechanical ventilation becomes necessary when noninvasive respiratory support cannot maintain adequate ventilation or oxygenation.

Indications may include severe respiratory failure, persistent respiratory acidosis, inability to maintain an airway, severe apnea, inadequate oxygenation despite CPAP, or profound respiratory fatigue.

Note: Mechanical ventilation can be lifesaving, but it also exposes immature lungs to mechanical stress.

Lung-Protective Ventilation

Premature lungs are particularly vulnerable to both barotrauma and volutrauma. Excessive airway pressure may injure or rupture delicate airspaces, while excessive tidal volume can overdistend developing lung tissue. For this reason, neonatal ventilation emphasizes the lowest effective pressures and volumes necessary to maintain acceptable gas exchange.

Suggested tidal volumes commonly fall around 4 to 6 mL/kg. Very low targets may be used depending on the infant’s disease and ventilatory strategy.

Permissive hypercapnia may be accepted in selected infants when necessary to avoid excessive ventilating pressures, provided that blood pH remains clinically acceptable.

PEEP is especially important because it helps prevent alveolar collapse at the end of expiration. In RDS, maintaining functional residual capacity is critical because surfactant-deficient alveoli have a strong tendency to collapse.

Volume-targeted ventilation may reduce some complications compared with traditional pressure-limited ventilation because it helps prevent excessive tidal volume as pulmonary compliance changes. Premature infants with RDS also tend to have short respiratory-system time constants, meaning their lungs fill and empty relatively quickly. Respiratory rate and inspiratory and expiratory times must therefore be chosen carefully.

High-Frequency Ventilation

High-frequency ventilation may be used when conventional ventilation is inadequate or when a different lung-protective approach is considered appropriate. High-frequency techniques deliver very rapid breaths, often using tidal volumes that are smaller than those employed during conventional ventilation.

High-frequency oscillatory ventilation is commonly used in neonatal respiratory care. Other approaches include high-frequency jet ventilation, high-frequency flow interruption, and high-frequency percussive ventilation.

These techniques require careful management of mean airway pressure, oxygen concentration, frequency, pressure amplitude, and blood gases. High-frequency ventilation does not eliminate the risk of lung injury, but it may provide an alternative means of supporting gas exchange in selected infants with severe pulmonary disease.

Oxygen Therapy in Premature Infants

Oxygen is essential for correcting hypoxemia, but excessive oxygen can be harmful to premature infants. The developing lungs contain relatively immature antioxidant defense systems, particularly because many of these systems normally mature during the final trimester of pregnancy.

High oxygen concentrations increase the formation of reactive oxygen species, which can damage pulmonary cells and contribute to inflammation, impaired lung development, and bronchopulmonary dysplasia.

For this reason, oxygen should be carefully titrated rather than routinely maximized. Pulse oximetry is commonly used for continuous monitoring. Arterial blood gases and transcutaneous oxygen monitoring may provide additional information when necessary.

Retinopathy of Prematurity

Retinopathy of prematurity is an important complication associated with prematurity and abnormal retinal vascular development.

Excessive oxygen exposure and large fluctuations between high and low oxygen levels can interfere with normal retinal vascularization. Severe disease can lead to retinal scarring, detachment, visual impairment, or blindness.

ROP is multifactorial, and low gestational age itself is a major risk factor. Sepsis, intraventricular hemorrhage, and low birth weight may also contribute. The risk of ROP reinforces the importance of maintaining adequate oxygenation without exposing premature infants to unnecessary hyperoxia.

Apnea of Prematurity

Apnea of prematurity is another common respiratory complication, particularly in infants born before approximately 32 weeks of gestation.

It occurs primarily because the neurologic control of respiration is immature. Premature infants may respond abnormally to changes in oxygen and carbon dioxide levels. Instead of reliably increasing ventilation during hypoxemia, they may decrease tidal volume and respiratory rate and eventually stop breathing. Apnea may be central, obstructive, or mixed.

Central apnea occurs when respiratory effort stops. Obstructive apnea occurs when respiratory effort continues but airflow is blocked. Mixed apnea contains features of both.

Clinically important apnea is often defined as a respiratory pause lasting approximately 20 seconds or longer, although shorter pauses may also be significant when accompanied by bradycardia, cyanosis, pallor, hypotonia, or oxygen desaturation.

Causes of Apnea Other Than Prematurity

Apnea in a premature infant should not automatically be attributed to developmental immaturity.

Other possible causes include:

• Sepsis
• Hypoxemia
• Anemia
• Intracranial hemorrhage
• Seizures
• Electrolyte abnormalities
• Acid-base disturbances
• Hypothermia or hyperthermia
• Maternal medications or opioid exposure
• Upper-airway obstruction
• Patent ductus arteriosus

Note: These conditions must be considered, particularly when apnea is new, unusually severe, or associated with other changes in the infant’s clinical condition.

Treating Apnea of Prematurity

Continuous cardiorespiratory monitoring is essential in infants with significant apnea. Pulse oximetry helps identify associated oxygen desaturation. Many episodes resolve spontaneously or respond to gentle tactile stimulation. If apnea persists, airway positioning and suctioning may be required.

If spontaneous breathing does not resume, bag-mask ventilation may be necessary. The infant should generally be ventilated using an appropriate oxygen concentration rather than automatically receiving 100% oxygen.

Caffeine citrate is commonly used to treat recurrent apnea because it stimulates respiratory-center activity and improves the response to carbon dioxide.

CPAP may also reduce mixed or obstructive apnea by maintaining upper-airway patency and improving functional residual capacity.

Infants with severe recurrent apnea that does not respond adequately to stimulation, caffeine, or noninvasive support may require mechanical ventilation. Apnea of prematurity generally improves as the respiratory-control system matures and often resolves around term-equivalent age.

Bronchopulmonary Dysplasia

Bronchopulmonary dysplasia is one of the most important chronic respiratory complications of extreme prematurity.

BPD occurs primarily in very premature and very-low-birth-weight infants whose developing lungs are exposed to inflammation, oxygen, positive-pressure ventilation, repeated alveolar collapse, infection, and other physiologic stresses.

Traditional BPD developed after severe RDS and prolonged exposure to relatively high oxygen concentrations and ventilator pressures. Modern BPD often reflects disrupted lung development in extremely premature infants who may have received comparatively gentler ventilation.

How BPD Develops

The immature lung is still forming alveoli and pulmonary blood vessels after premature birth. Repeated alveolar collapse and reopening can injure lung tissue. Excessive tidal volume causes overdistention, while excessive oxygen promotes oxidative injury and inflammation.

Persistent inflammatory activity can interfere with normal alveolar development. Instead of forming large numbers of small alveoli with extensive surface area, the lung may develop fewer, larger, simplified airspaces.

Abnormal vascular development may also occur, increasing the risk of pulmonary hypertension. The result is impaired lung growth combined with varying degrees of airway obstruction, inflammation, edema, fibrosis, and abnormal pulmonary mechanics.

Preventing and Managing BPD

Prevention focuses on limiting additional lung injury from the beginning of respiratory care. Noninvasive support should be used whenever adequate. Mechanical ventilation should be reduced or discontinued as soon as clinically appropriate. Oxygen should be administered at the lowest concentration that provides acceptable oxygenation.

When invasive ventilation is required, low tidal volumes, appropriate PEEP, and other lung-protective strategies should be used. Surfactant therapy and caffeine may reduce the need for prolonged invasive ventilation in selected premature infants.

Nutritional support is also important because infants with chronic lung disease have increased energy requirements while simultaneously needing adequate nutrients for lung growth.

Fluid management may help reduce pulmonary edema. Diuretics may be used in selected infants. Bronchodilators can be considered when significant airway obstruction or bronchospasm is present.

Corticosteroids may temporarily improve pulmonary function and assist ventilator weaning in certain infants, but their potential benefits must be weighed against possible adverse effects on neurologic and lung development. Some infants with severe BPD require supplemental oxygen for weeks or months and may eventually be discharged home while still receiving oxygen.

Other Complications of Prematurity

Respiratory disease occurs alongside several other potential complications that can affect the management and outcome of premature infants. Intraventricular hemorrhage is especially important in extremely premature infants because fragile cerebral vessels are vulnerable to fluctuations in blood flow and pressure.

Necrotizing enterocolitis can cause severe intestinal injury and infection. Sepsis is also more common because premature infants have immature immune defenses.

Neurologic and developmental complications can include cerebral palsy, developmental delay, hearing impairment, and visual problems. These complications illustrate why neonatal care focuses not only on immediate survival but also on protecting long-term growth and neurodevelopment.

Temperature Regulation

Premature infants have difficulty maintaining body temperature because they have relatively little insulating fat, immature skin, limited metabolic reserves, and a large surface-area-to-body-mass ratio.

Hypothermia increases oxygen consumption and metabolic demand, which can worsen respiratory instability.

Maintaining a neutral thermal environment is therefore an important part of respiratory management. Incubators may be particularly useful in very-low-birth-weight infants because they provide thermal support while helping limit insensible water loss.

Nutrition and Fluid Management

Adequate nutrition is essential for ongoing lung growth and recovery. Very premature infants may initially require intravenous fluids and nutritional support because they cannot safely receive sufficient enteral feeding.

Both excessive and inadequate fluid administration can create problems. Excessive fluids may worsen pulmonary edema and contribute to complications such as patent ductus arteriosus, while inadequate intake can impair tissue growth.

Infants with bronchopulmonary dysplasia frequently require increased caloric intake because respiratory effort and chronic illness increase energy expenditure. Nutrition should therefore be considered part of respiratory care rather than a separate concern.

Monitoring the Premature Infant

Premature infants with respiratory illness require close and repeated assessment. Important variables may include respiratory rate, heart rate, oxygen saturation, blood pressure, temperature, blood gases, serum glucose, electrolytes, and hematocrit.

Pulse oximetry provides continuous information about oxygen saturation. Transcutaneous oxygen and carbon dioxide monitoring may be useful when repeated blood sampling is undesirable.

Mechanically ventilated infants require additional monitoring of tidal volume, airway pressures, respiratory rate, ventilator synchrony, oxygen requirements, and endotracheal tube position.

Chest imaging may be necessary when complications such as pneumothorax, pulmonary interstitial emphysema, atelectasis, or endotracheal tube malposition are suspected. Close monitoring is particularly important after interventions such as surfactant administration because lung mechanics and oxygenation can improve rapidly.

Aerosol Therapy in Premature Infants

Aerosolized medications present unique challenges in premature infants. These patients have very small tidal volumes, rapid respiratory rates, short inspiratory times, and narrow airways. As a result, only a small portion of the aerosol generated by a device may actually reach the lungs.

Neonates cannot voluntarily perform slow inhalations, deep breaths, or breath holds. They are also commonly nasal breathers. Crying, agitation, mask leaks, and poorly fitted interfaces can substantially reduce aerosol deposition.

Aerosol administration becomes even more complicated during mechanical ventilation. Drug delivery may be affected by humidification, ventilator flow, respiratory rate, endotracheal tube diameter, aerosol particle size, and nebulizer placement.

Vibrating mesh nebulizers can be useful because they do not introduce additional gas flow into the ventilator circuit. Medication effects should be evaluated clinically rather than assuming that a proportionally reduced adult dose will reliably produce an appropriate neonatal lung dose.

Weaning and Extubation

Mechanical ventilation should be reduced as soon as the infant demonstrates sufficient improvement. Weaning may involve lowering oxygen concentration, ventilator rate, inspiratory pressure, or other forms of respiratory assistance while evaluating the infant’s response.

Extubation does not necessarily mean respiratory support is no longer needed. Many premature infants are extubated directly to nasal CPAP, high-flow nasal cannula, or another form of noninvasive support.

This strategy provides continued assistance while reducing complications associated with an endotracheal tube and prolonged invasive ventilation. Successful extubation depends on adequate respiratory drive, acceptable oxygenation, sufficient ventilation, manageable work of breathing, and the ability to protect and maintain the airway.

Long-Term Outlook

The prognosis of a premature infant is closely related to gestational age, birth weight, severity of respiratory disease, and associated complications. Advances in antenatal corticosteroids, surfactant replacement, neonatal resuscitation, noninvasive ventilation, oxygen monitoring, nutrition, and lung-protective mechanical ventilation have substantially improved survival.

However, extremely premature infants remain vulnerable to chronic respiratory problems. Some survivors demonstrate increased airway resistance, reduced pulmonary compliance, oxygen desaturation, recurrent respiratory infections, wheezing, pulmonary hypertension, or persistent oxygen dependence.

Long-term neurodevelopmental outcomes are also important. Follow-up may therefore involve respiratory specialists, pediatricians, neurologists, developmental services, nutrition specialists, and other healthcare professionals.

Premature Infant Respiratory Care Practice Questions

1. What is a premature infant?
A premature infant is a newborn delivered before 37 completed weeks of gestation.

2. Why are premature infants at increased risk for respiratory complications?
Their lungs, pulmonary circulation, respiratory-control mechanisms, chest wall, and antioxidant defenses may not be fully developed.

3. How does decreasing gestational age affect the risk of respiratory problems in premature infants?
The risk and severity of respiratory complications generally increase as gestational age decreases.

4. What is the primary cause of respiratory distress syndrome (RDS) in premature infants?
RDS primarily results from inadequate or immature pulmonary surfactant combined with incomplete lung development.

5. What is the main function of pulmonary surfactant?
Pulmonary surfactant reduces alveolar surface tension, helping prevent alveolar collapse during expiration.

6. Which cells in the lungs are responsible for producing pulmonary surfactant?
Type II pneumocytes produce pulmonary surfactant.

7. What happens to the alveoli when surfactant is deficient?
The alveoli become unstable and are more likely to collapse during expiration, producing atelectasis.

8. How does surfactant deficiency affect lung compliance?
Surfactant deficiency decreases lung compliance, making the lungs more difficult to expand.

9. Why does RDS increase the work of breathing in a premature infant?
Collapsed, poorly compliant alveoli require the infant to generate greater inspiratory pressure to expand the lungs.

10. How does widespread atelectasis contribute to hypoxemia in RDS?
Atelectasis creates poorly ventilated lung regions that continue receiving blood flow, causing intrapulmonary shunting and impaired oxygenation.

11. What effect can hypoxemia and acidosis have on the pulmonary circulation of a premature infant?
They can increase pulmonary vascular resistance and pulmonary arterial pressure, potentially worsening right-to-left shunting.

12. What are common clinical signs of respiratory distress syndrome in a premature infant?
Common signs include tachypnea, nasal flaring, expiratory grunting, chest retractions, cyanosis, and increasing oxygen requirements.

13. Why does a premature infant with RDS produce expiratory grunting?
Grunting creates positive pressure during expiration, helping maintain lung volume and reduce alveolar collapse.

14. Why are chest retractions often prominent in premature infants with RDS?
The premature chest wall is highly compliant, so it is easily pulled inward when the infant generates greater inspiratory pressure.

15. What are typical chest radiograph findings in neonatal respiratory distress syndrome?
Typical findings include low lung volumes, diffuse ground-glass or reticulogranular opacities, and air bronchograms.

16. What causes air bronchograms to appear on a chest radiograph in RDS?
Air-filled bronchi become visible because they are surrounded by collapsed or poorly aerated lung tissue.

17. How can antenatal corticosteroids benefit an infant at risk for premature delivery?
They accelerate fetal lung maturation and improve surfactant production and function, reducing the risk and severity of RDS.

18. What is an important initial form of respiratory support for a spontaneously breathing premature infant with RDS?
Nasal continuous positive airway pressure (CPAP) is an important initial form of respiratory support.

19. How does CPAP improve respiratory function in a premature infant with RDS?
CPAP maintains positive airway pressure, stabilizes alveoli, increases functional residual capacity, and reduces repeated alveolar collapse.

20. Why is noninvasive respiratory support preferred over prolonged endotracheal ventilation when possible?
Avoiding prolonged invasive ventilation reduces the risk of pressure-related, volume-related, and inflammatory lung injury.

21. When may surfactant replacement therapy be considered in a premature infant receiving CPAP?
It may be considered when respiratory distress becomes significant, severe or recurrent apnea occurs, or the infant requires an FiO₂ greater than approximately 0.40 while receiving CPAP.

22. How is exogenous surfactant administered to a premature infant?
Exogenous surfactant is delivered directly into the trachea so it can spread across the alveolar surfaces.

23. Why must ventilator settings be reassessed quickly after surfactant administration?
Lung compliance may improve rapidly, causing previously appropriate pressures to deliver excessive tidal volumes and increase the risk of lung injury.

24. What tidal volume range may be used during lung-protective mechanical ventilation of a premature infant?
A tidal volume of approximately 4 to 6 mL/kg may be targeted, depending on the infant’s clinical condition and ventilation strategy.

25. What is the primary purpose of PEEP during mechanical ventilation of a premature infant with RDS?
PEEP helps prevent alveolar collapse at the end of expiration and maintains functional residual capacity.

26. What is the INSURE approach used in premature infants with RDS?
INSURE stands for intubation, surfactant administration, and extubation, followed by noninvasive respiratory support such as nasal CPAP.

27. Why is early extubation encouraged in premature infants?
Early extubation reduces exposure to invasive mechanical ventilation and may decrease ventilator-associated lung injury.

28. What is high-flow nasal cannula used for in premature infants?
High-flow nasal cannula can provide noninvasive respiratory support, assist oxygenation, reduce dead-space carbon dioxide, and help avoid or shorten invasive ventilation.

29. How does nasal intermittent mandatory ventilation differ from CPAP?
It provides continuous positive airway pressure along with intermittent positive-pressure breaths, offering more ventilatory assistance than CPAP alone.

30. When may mechanical ventilation become necessary in a premature infant?
Mechanical ventilation may be required when noninvasive support cannot maintain adequate ventilation, oxygenation, airway protection, or respiratory effort.

31. Why are premature lungs especially vulnerable to volutrauma?
Their immature, delicate lung tissue can be overdistended easily when excessive tidal volumes are delivered.

32. Why are premature lungs especially vulnerable to barotrauma?
Excessive airway pressures can injure fragile developing lung tissue and may contribute to air-leak syndromes.

33. What is permissive hypercapnia in neonatal mechanical ventilation?
Permissive hypercapnia is the acceptance of a moderately elevated PaCO₂ to avoid excessive ventilator pressures or tidal volumes, provided the pH remains acceptable.

34. Why may volume-targeted ventilation be beneficial in premature infants?
It helps limit excessive tidal volume as lung compliance changes, which may reduce ventilator-associated complications.

35. Why do infants with RDS often have short respiratory-system time constants?
Their lungs are relatively stiff and may empty quickly because of reduced compliance and small airway dimensions.

36. What is bronchopulmonary dysplasia (BPD)?
BPD is a chronic lung disorder of prematurity associated with disrupted lung development and injury from factors such as oxygen exposure, inflammation, and positive-pressure ventilation.

37. Which premature infants are at greatest risk for developing BPD?
Extremely premature and very-low-birth-weight infants are at the greatest risk.

38. How can excessive oxygen exposure contribute to BPD?
Excess oxygen promotes oxidative stress and inflammation that can injure immature lung tissue and interfere with normal alveolar development.

39. How can repeated alveolar collapse and reopening contribute to lung injury?
Repeated collapse and reinflation create mechanical stress that can damage the immature alveoli and promote inflammation.

40. What happens to alveolar development in modern bronchopulmonary dysplasia?
Normal alveolarization may be disrupted, resulting in fewer and larger alveoli with reduced gas-exchange surface area.

41. Why can pulmonary hypertension develop in infants with BPD?
Abnormal pulmonary vascular development, chronic hypoxemia, and lung injury can increase pulmonary vascular resistance.

42. What is an important respiratory goal in the management of BPD?
An important goal is to provide adequate gas exchange while minimizing additional oxygen and ventilator-related lung injury.

43. Why is nutrition important for premature infants with BPD?
Adequate nutrition supports lung growth and overall development while meeting the increased energy demands caused by chronic respiratory illness.

44. Why might diuretics be used in an infant with BPD?
Diuretics may be used to reduce pulmonary edema and improve lung mechanics in selected infants.

45. When may bronchodilators be considered in an infant with BPD?
They may be considered when the infant has significant airway obstruction or episodic bronchospasm.

46. What is apnea of prematurity?
Apnea of prematurity is a developmental breathing disorder caused primarily by immature respiratory control in premature infants.

47. What are the three major types of apnea seen in premature infants?
The three types are central apnea, obstructive apnea, and mixed apnea.

48. What occurs during central apnea?
Respiratory effort temporarily stops because the central nervous system does not generate an effective breathing signal.

49. What occurs during obstructive apnea?
Respiratory effort continues, but airflow is blocked because of upper-airway obstruction.

50. What defines mixed apnea?
Mixed apnea contains both central and obstructive components during the same episode.

51. What clinical features can make an apneic episode significant in a premature infant?
Bradycardia, cyanosis, pallor, decreased muscle tone, and oxygen desaturation can make even a relatively short apnea episode clinically significant.

52. Why should apnea in a premature infant not automatically be attributed to prematurity?
Other problems such as sepsis, hypoxemia, anemia, intracranial hemorrhage, seizures, temperature abnormalities, and medication exposure can also cause apnea.

53. What medication is commonly used to treat recurrent apnea of prematurity?
Caffeine citrate is commonly used to stimulate respiratory activity and reduce recurrent apnea.

54. How does caffeine help premature infants with apnea?
Caffeine stimulates the respiratory center and improves the infant’s responsiveness to carbon dioxide.

55. How can CPAP help reduce apnea of prematurity?
CPAP can maintain upper-airway patency, improve functional residual capacity, and reduce obstructive or mixed apnea episodes.

56. What may be required if apnea persists despite stimulation, caffeine, and noninvasive support?
Mechanical ventilation may be required for severe or recurrent apnea that does not respond to other treatments.

57. At what developmental stage does apnea of prematurity usually improve?
It generally improves as respiratory control matures, often near term-equivalent age.

58. Is apnea of prematurity considered a cause of increased sudden infant death syndrome risk?
No, apnea of prematurity itself is not considered a cause of increased risk for sudden infant death syndrome.

59. Why are premature infants more vulnerable to oxygen toxicity than term infants?
Their antioxidant defense systems are immature because many normally develop during the final trimester of pregnancy.

60. What are reactive oxygen species?
Reactive oxygen species are chemically reactive molecules generated during oxygen metabolism that can damage immature lung tissue when produced in excess.

61. Why should supplemental oxygen be carefully titrated in premature infants?
Both hypoxemia and excessive oxygen exposure can cause harm, so oxygen should be adjusted to maintain adequate oxygenation while avoiding unnecessary hyperoxia.

62. What is retinopathy of prematurity?
Retinopathy of prematurity is abnormal retinal vascular development that can occur in premature infants and may lead to visual impairment or blindness.

63. How can excessive oxygen exposure contribute to retinopathy of prematurity?
Excessive oxygen and large fluctuations in oxygen levels can disrupt normal retinal vascular development.

64. Why are oxygen saturation targets often lower in premature infants than in older patients?
Lower targets help provide adequate oxygenation while reducing the risks associated with hyperoxia, including retinal and lung injury.

65. What role does pulse oximetry play in the care of premature infants?
Pulse oximetry provides continuous noninvasive monitoring of oxygen saturation and helps guide oxygen therapy.

66. What is the purpose of transcutaneous oxygen and carbon dioxide monitoring in premature infants?
It provides noninvasive estimates of oxygenation and ventilation while reducing the need for frequent blood sampling.

67. Why is body temperature control important in premature infants?
Hypothermia increases oxygen consumption and metabolic demand, which can worsen respiratory stress.

68. Why are premature infants prone to heat loss?
They have thin skin, limited fat stores, a high surface-area-to-body-mass ratio, and immature temperature-regulation mechanisms.

69. Why can excessive fluid administration worsen respiratory problems in premature infants?
Excess fluid can contribute to pulmonary edema and may worsen conditions such as patent ductus arteriosus and bronchopulmonary dysplasia.

70. Why is adequate nutrition essential for premature lung development?
Adequate calories and nutrients support continued alveolar growth, tissue repair, and overall development.

71. What is a patent ductus arteriosus?
A patent ductus arteriosus is persistence of the fetal connection between the pulmonary artery and aorta after birth.

72. How can a patent ductus arteriosus affect a premature infant’s respiratory status?
It can increase pulmonary blood flow and contribute to pulmonary edema, worsening respiratory distress.

73. What is intraventricular hemorrhage?
Intraventricular hemorrhage is bleeding into or around the brain’s ventricular system, most often occurring in very premature infants with fragile cerebral vessels.

74. Why are extremely premature infants at increased risk for intraventricular hemorrhage?
Their cerebral blood vessels are fragile and vulnerable to fluctuations in cerebral blood flow and pressure.

75. What is necrotizing enterocolitis?
Necrotizing enterocolitis is a serious intestinal disorder involving inflammation and injury of the bowel wall that occurs disproportionately in premature infants.

76. What is the Ballard assessment used for in premature infants?
The Ballard assessment estimates gestational age using physical and neuromuscular characteristics.

77. How does muscle tone generally differ between more mature and less mature newborns?
More mature newborns typically demonstrate greater flexion and muscle tone than very premature infants.

78. What does a lecithin-to-sphingomyelin ratio of approximately 2:1 generally suggest?
It generally suggests adequate fetal lung maturity and a relatively low risk of respiratory distress syndrome.

79. What does the presence of phosphatidylglycerol in amniotic fluid indicate?
It supports the presence of advanced fetal lung maturity and more developed surfactant production.

80. Why is low birth weight an important risk factor in premature infants?
Low birth weight is often associated with greater developmental immaturity, reduced physiologic reserves, and increased risk of complications.

81. Why may a premature infant require an incubator?
An incubator helps maintain a stable thermal environment and can reduce heat and insensible water loss.

82. What is the main purpose of preductal pulse oximetry after birth?
It helps assess oxygenation using a site that reflects blood oxygen levels before significant ductal mixing.

83. Where is preductal pulse oximetry usually measured in a newborn?
It is usually measured on the right hand or right wrist.

84. Why should adult oxygen saturation expectations not be applied immediately after birth?
Normal newborn oxygen saturation rises gradually during the first several minutes of life as cardiopulmonary transition occurs.

85. What is the purpose of the Apgar assessment?
The Apgar assessment provides a rapid evaluation of the newborn’s heart rate, respiratory effort, muscle tone, reflex response, and color.

86. Should respiratory resuscitation be delayed in order to complete an Apgar score?
No. Necessary respiratory support or resuscitation should begin immediately and should not be delayed for scoring.

87. Why can a premature infant fatigue rapidly during respiratory distress?
Premature infants have limited energy reserves and may need to generate substantial effort to expand poorly compliant lungs.

88. What is functional residual capacity?
Functional residual capacity is the amount of air remaining in the lungs at the end of a normal expiration.

89. Why is maintaining functional residual capacity especially important in premature infants with RDS?
Maintaining functional residual capacity helps keep alveoli open and provides a reservoir of gas for continued oxygen exchange between breaths.

90. What is intrapulmonary shunting?
Intrapulmonary shunting occurs when blood passes through lung regions that are perfused but inadequately ventilated, resulting in poor oxygenation.

91. How does atelectasis increase intrapulmonary shunting?
Collapsed alveoli receive little or no ventilation while blood flow may continue through their surrounding capillaries.

92. Why can pulmonary edema worsen respiratory distress in a premature infant?
Fluid within or around the alveoli decreases effective gas exchange and can further reduce lung compliance.

93. What is pulmonary interstitial emphysema?
Pulmonary interstitial emphysema is an air-leak complication in which gas escapes from alveoli into the pulmonary interstitial tissues.

94. Why are premature infants vulnerable to pulmonary interstitial emphysema?
Their immature lungs are fragile and can be damaged by excessive airway pressures or uneven ventilation.

95. What is a pneumothorax?
A pneumothorax is the accumulation of air in the pleural space, which can partially or completely collapse the affected lung.

96. Why should inspired oxygen concentration often be reduced after successful surfactant therapy?
Improved alveolar stability and gas exchange can rapidly increase oxygenation, making the previous FiO₂ unnecessarily high.

97. Why can surfactant administration temporarily cause bradycardia or oxygen desaturation?
The liquid surfactant can briefly obstruct small airways or interfere with ventilation while it is being distributed through the lungs.

98. Why may more than one dose of surfactant be given to a premature infant?
Additional doses may be needed when surfactant deficiency and significant respiratory distress persist after the initial treatment.

99. What is the overall goal of respiratory support in a premature infant?
The goal is to maintain adequate oxygenation and ventilation while minimizing additional injury to the developing lungs.

100. Why is minimizing invasive ventilation an important principle in premature infant care?
Reducing invasive ventilation limits exposure to excessive pressure, excessive tidal volume, airway trauma, and inflammation that can disrupt normal lung development.

Final Thoughts

Premature infants face respiratory challenges because breathing begins before normal lung development, surfactant production, pulmonary circulation, and respiratory control have fully matured.

Respiratory care focuses on supporting gas exchange while preventing additional injury to fragile developing lungs. Early CPAP, selective surfactant therapy, controlled oxygen administration, caffeine for apnea, appropriate PEEP, low tidal volumes, and timely weaning from mechanical ventilation are central strategies.

Successful care also requires attention to temperature, nutrition, fluid balance, infection, and long-term development. The overall goal is to provide enough support for survival while allowing the lungs to continue developing with minimal treatment-related damage.